« Previous
Next »
American Journal of Kidney Diseases
Volume 50, Issue 2
, Pages 289-295
, August 2007
Treatment of Dialysis Catheter–Related Staphylococcus aureus Bacteremia With an Antibiotic Lock: A Quality Improvement Report
References
- . Dialysis catheter-related bacteremia: Treatment and prophylaxis. Am J Kidney Dis. 2004;44:779–791
- . 2003 Annual Report: End-Stage Renal Disease Clinical Performance Measures Project. Am J Kidney Dis. 2004;44(suppl 2):S1–S92
- . Bacterial biofilms: A common cause of persistent infections. Science. 1999;284:1318–1322
- . Biofilm formation: A clinically relevant microbiologic process. Clin Infect Dis. 2001;33:1387–1392
- Management of hemodialysis catheter related bacteremia with an adjunctive antibiotic lock solution. Kidney Int. 2002;61:1136–1142
- . Treatment of catheter-related bacteremia with an antibiotic lock protocol: Effect of bacterial pathogen. Nephrol Dial Transplant. 2004;19:1237–1244
- . Treatment of haemodialysis catheter-related infections. Nephrol Dial Transplant. 2002;17:1149–1150
- Antibiotic-lock therapy for long-term intravascular catheter-related bacteremia: Results of an open, non-comparative study. J Antimicrob Chemother. 2006;57:1172–1180
- . Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: Randomized, placebo-controlled trial. J Antimicrob Chemother. 2004;55:90–94
- . Tunnelled hemodialysis catheter bacteraemia: Risk factors for bacteraemia recurrence, infectious complications and mortality. Nephrol Dial Transplant. 2006;21:1024–1031
- . Use of vancomycin in high-flux hemodialysis: Experience with 130 courses of therapy. Kidney Int. 1996;50:929–936
- . Cefazolin in chronic hemodialysis patients: A safe, effective alternative to vancomycin. Am J Kidney Dis. 1998;32:401–409
- A multidisciplinary approach to hemodialysis access: Prospective evaluation. Kidney Int. 1998;53:473–479
- Bacteremia associated with tunneled dialysis catheters: Comparison of two treatment strategies. Kidney Int. 2000;57:2151–2155
- Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis. 2005;40:695–703
- . Outcome following haemodialysis catheter-related Staphylococcus aureus bacteraemia. J Hosp Infect. 1999;41:223–228
- . A prospective randomized trial of urokinase as an adjuvant in the treatment of proven Hickman catheter sepsis. J Pediatr Surg. 1998;33:714–716
- Adjunctive antibiotic/anticoagulant lock therapy in the treatment of bacteremia associated with the use of a subcutaneously implanted hemodialysis access device. ASAIO J. 2000;46:767–770
- Successful treatment of hemodialysis catheter-related sepsis without catheter removal. Nephrol Dial Transplant. 1993;8:231–234
- . Antibiotic-lock technique: A new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. J Parenter Enteral Nutr. 1988;12:185–189
- . Intravascular-catheter-related infections. Lancet. 1998;351:1738–1739(letter)
- Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001;32:1249–1272
- . Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis. 1999;34:1114–1124
- . Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol. 1999;10:1045–1049
Originally published online as doi:10.1053/j.ajkd.2007.04.014 on June 13, 2007.
PII: S0272-6386(07)00737-8
doi: 10.1053/j.ajkd.2007.04.014
© 2007 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
« Previous
Next »
American Journal of Kidney Diseases
Volume 50, Issue 2
, Pages 289-295
, August 2007
